SEARCH
Avoid Sun Pharma, says Ashwani Gujral
CNBC-TV18
2019-01-23
Views
8
Description
Share / Embed
Download This Video
Report
In an interview to CNBC-TV18, market expert Ashwani Gujral and Dipan Mehta Member of BSE & NSE, shared their reading and outlook on specific stocks and sectors.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://vntv.net//embed/x7156as" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
24:56
Avoid Sun Pharma and SPARC, says Ashwani Gujral
25:38
Buy JSPL, HPCL & Sun TV, says stock analyst Ashwani Gujral
01:11
Buy Cipla, Sun Pharma, Sell Tata Steel : Ashwani Gujral
02:38
Buy Sun Pharma, Idea, sell Wipro, RIL: Ashwani Gujral
23:11
Negative on DHFL and positive on Edelweiss, says Ashwani Gujral
25:17
Buy Avenue Supermarts & sell Bank of Baroda, Biocon, says market expert Ashwani Gujral
22:57
Buy Edelweiss Financial; sell Lupin and Shriram Transport, says Ashwani Gujral
25:05
Buy Balrampur Chini Mills, Godrej Properties & JSPL, says Ashwani Gujral
22:53
Positive on Dabur and ICICI Prudential, says Ashwani Gujral
23:37
SBI likely to remain rangebound between Rs 260 and Rs 295, says Ashwani Gujral
03:00
Buy BF Utilities and Hero MotoCorp says Ashwani Gujral
03:30
Ashwani Gujral says buy Divi's Lab, Delta Corp and SBI
